Of the more than 13,000 children who survived acute respiratory distress syndrome (ARDS), there was a 30.0% probability of hospital readmission within 1 year, 50% of which are likely to occur ...

By David Bautz, PhD NASDAQ:EDSA READ THE FULL EDSA RESEARCH REPORT Business Update Update on EB05 Development in ARDS Edesa Biotech, Inc. (NASDAQ:EDSA) is developing EB05 (paridiprubart) as a ...

Among those with both ARDS and PH, 36.8% died in the hospital, which was higher than the in-hospital mortality rate of 24.6% observed among those with ARDS and without PH.